Unraveling the antifungal activity of a South American rattlesnake toxin crotamine
Autor(a) principal: | |
---|---|
Data de Publicação: | 2013 |
Outros Autores: | , , , , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da UNIFESP |
Texto Completo: | http://dx.doi.org/10.1016/j.biochi.2012.09.019 http://repositorio.unifesp.br/handle/11600/35889 |
Resumo: | Crotamine is a highly basic peptide from the venom of Crotalus durissus terrificus rattlesnake. Its common gene ancestry and structural similarity with the beta-defensins, mainly due to an identical disulfide bond pattern, stimulated us to assess the antimicrobial properties of native, recombinant, and chemically synthesized crotamine. Antimicrobial activities against standard strains and clinical isolates were analyzed by the colorimetric microdilution method showing a weak antibacterial activity against both Gram-positive and Gram-negative bacteria [MIC (Minimum Inhibitory Concentration) of 50->200 mu g/mL], with the exception of Micrococcus luteus [MIC ranging from 1 to 2 mu g/mL]. No detectable activity was observed for the filamentous fungus Aspergillus fumigatus and Trichophyton rubrum at concentrations up to 125 mu g/mL. However, a pronounced antifungal activity against Candida spp., Trichosporon spp., and Cryptococcus neoformans [12.5-50.0 mu g/mL] was observed. Chemically produced synthetic crotamine in general displayed MIC values similar to those observed for native crotamine, whereas recombinant crotamine was overridingly more potent in most assays. On the other hand, derived short linear peptides were not very effective apart from a few exceptions. Pronounced ultrastructure alteration in Candida albicans elicited by crotamine was observed by electron microscopy analyses. the peculiar specificity for highly proliferating cells was confirmed here showing potential low cytotoxic effect of crotamine against nontumoral mammal cell lines (HEK293, PC12, and primary culture astrocyte cells) compared to tumoral B16F10 cells, and no hemolytic activity was observed. Taken together these results suggest that, at low concentration, crotamine is a potentially valuable anti-yeast or candicidal agent, with low harmful effects on normal mammal cells, justifying further studies on its mechanisms of action aiming medical and industrial applications. (C) 2012 Elsevier Masson SAS. All rights reserved. |
id |
UFSP_e105371daa31f4f62af5e70ca4f175b4 |
---|---|
oai_identifier_str |
oai:repositorio.unifesp.br/:11600/35889 |
network_acronym_str |
UFSP |
network_name_str |
Repositório Institucional da UNIFESP |
repository_id_str |
3465 |
spelling |
Unraveling the antifungal activity of a South American rattlesnake toxin crotamineRattlesnake toxinAntimicrobial activityAmphipathic peptideClinical strainCrotamine is a highly basic peptide from the venom of Crotalus durissus terrificus rattlesnake. Its common gene ancestry and structural similarity with the beta-defensins, mainly due to an identical disulfide bond pattern, stimulated us to assess the antimicrobial properties of native, recombinant, and chemically synthesized crotamine. Antimicrobial activities against standard strains and clinical isolates were analyzed by the colorimetric microdilution method showing a weak antibacterial activity against both Gram-positive and Gram-negative bacteria [MIC (Minimum Inhibitory Concentration) of 50->200 mu g/mL], with the exception of Micrococcus luteus [MIC ranging from 1 to 2 mu g/mL]. No detectable activity was observed for the filamentous fungus Aspergillus fumigatus and Trichophyton rubrum at concentrations up to 125 mu g/mL. However, a pronounced antifungal activity against Candida spp., Trichosporon spp., and Cryptococcus neoformans [12.5-50.0 mu g/mL] was observed. Chemically produced synthetic crotamine in general displayed MIC values similar to those observed for native crotamine, whereas recombinant crotamine was overridingly more potent in most assays. On the other hand, derived short linear peptides were not very effective apart from a few exceptions. Pronounced ultrastructure alteration in Candida albicans elicited by crotamine was observed by electron microscopy analyses. the peculiar specificity for highly proliferating cells was confirmed here showing potential low cytotoxic effect of crotamine against nontumoral mammal cell lines (HEK293, PC12, and primary culture astrocyte cells) compared to tumoral B16F10 cells, and no hemolytic activity was observed. Taken together these results suggest that, at low concentration, crotamine is a potentially valuable anti-yeast or candicidal agent, with low harmful effects on normal mammal cells, justifying further studies on its mechanisms of action aiming medical and industrial applications. (C) 2012 Elsevier Masson SAS. All rights reserved.Universidade Federal de São Paulo UNIFESP, Dept Farmacol, BR-04044020 São Paulo, BrazilUniversidade Federal de São Paulo UNIFESP, Dept Med, BR-04044020 São Paulo, BrazilUniv São Paulo, Dept Bioquim & Imunol, BR-14049 Ribeirao Preto, BrazilUniv Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USAUniv Maryland, Dept Biochem & Mol Biol, Baltimore, MD 21201 USAUniversidade Federal de São Paulo UNIFESP, Dept Bioquim, BR-04044020 São Paulo, BrazilInst Butantan, Lab Bioquim & Biofis, BR-05503900 São Paulo, BrazilUniversidade Federal de São Paulo UNIFESP, Dept Ginecol, BR-04044020 São Paulo, BrazilCBA, Lab Bioquim & Biol Mol, Manaus, Amazonas, BrazilUniv Maryland Baltimore Cty, Dept Chem & Biochem, Baltimore, MD 21250 USAInst Butantan, Ctr Toxinol Aplicada CAT CEPID, BR-05503900 São Paulo, BrazilUniversidade Federal de São Paulo UNIFESP, Dept Farmacol, BR-04044020 São Paulo, BrazilUniversidade Federal de São Paulo UNIFESP, Dept Med, BR-04044020 São Paulo, BrazilUniversidade Federal de São Paulo UNIFESP, Dept Bioquim, BR-04044020 São Paulo, BrazilUniversidade Federal de São Paulo UNIFESP, Dept Ginecol, BR-04044020 São Paulo, BrazilWeb of ScienceFundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)University of Maryland Baltimore County Designated Research Initiative FundElsevier B.V.Universidade Federal de São Paulo (UNIFESP)Universidade de São Paulo (USP)Univ MarylandInst ButantanCBAUniv Maryland Baltimore CtyYamane, Érica Sayuri [UNIFESP]Bizerra, Fernando César [UNIFESP]Oliveira, Eduardo B.Moreira, Jéssica Tanaka [UNIFESP]Rajabi, MohsenNunes, Gabriel Luiz Cocco [UNIFESP]Souza, Ana O. deSilva, Ismael Dale Cotrim Guerreiro da [UNIFESP]Yamane, TetsuoKarpel, Richard L.Silva, Pedro I.Hayashi, Mirian Akemi Furuie [UNIFESP]2016-01-24T14:31:09Z2016-01-24T14:31:09Z2013-02-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion231-240application/pdfhttp://dx.doi.org/10.1016/j.biochi.2012.09.019Biochimie. Paris: Elsevier France-editions Scientifiques Medicales Elsevier, v. 95, n. 2, p. 231-240, 2013.10.1016/j.biochi.2012.09.019WOS000315614200012.pdf0300-9084http://repositorio.unifesp.br/handle/11600/35889WOS:000315614200012engBiochimieinfo:eu-repo/semantics/openAccesshttp://www.elsevier.com/about/open-access/open-access-policies/article-posting-policyreponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESP2024-08-08T18:04:30Zoai:repositorio.unifesp.br/:11600/35889Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestbiblioteca.csp@unifesp.bropendoar:34652024-08-08T18:04:30Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false |
dc.title.none.fl_str_mv |
Unraveling the antifungal activity of a South American rattlesnake toxin crotamine |
title |
Unraveling the antifungal activity of a South American rattlesnake toxin crotamine |
spellingShingle |
Unraveling the antifungal activity of a South American rattlesnake toxin crotamine Yamane, Érica Sayuri [UNIFESP] Rattlesnake toxin Antimicrobial activity Amphipathic peptide Clinical strain |
title_short |
Unraveling the antifungal activity of a South American rattlesnake toxin crotamine |
title_full |
Unraveling the antifungal activity of a South American rattlesnake toxin crotamine |
title_fullStr |
Unraveling the antifungal activity of a South American rattlesnake toxin crotamine |
title_full_unstemmed |
Unraveling the antifungal activity of a South American rattlesnake toxin crotamine |
title_sort |
Unraveling the antifungal activity of a South American rattlesnake toxin crotamine |
author |
Yamane, Érica Sayuri [UNIFESP] |
author_facet |
Yamane, Érica Sayuri [UNIFESP] Bizerra, Fernando César [UNIFESP] Oliveira, Eduardo B. Moreira, Jéssica Tanaka [UNIFESP] Rajabi, Mohsen Nunes, Gabriel Luiz Cocco [UNIFESP] Souza, Ana O. de Silva, Ismael Dale Cotrim Guerreiro da [UNIFESP] Yamane, Tetsuo Karpel, Richard L. Silva, Pedro I. Hayashi, Mirian Akemi Furuie [UNIFESP] |
author_role |
author |
author2 |
Bizerra, Fernando César [UNIFESP] Oliveira, Eduardo B. Moreira, Jéssica Tanaka [UNIFESP] Rajabi, Mohsen Nunes, Gabriel Luiz Cocco [UNIFESP] Souza, Ana O. de Silva, Ismael Dale Cotrim Guerreiro da [UNIFESP] Yamane, Tetsuo Karpel, Richard L. Silva, Pedro I. Hayashi, Mirian Akemi Furuie [UNIFESP] |
author2_role |
author author author author author author author author author author author |
dc.contributor.none.fl_str_mv |
Universidade Federal de São Paulo (UNIFESP) Universidade de São Paulo (USP) Univ Maryland Inst Butantan CBA Univ Maryland Baltimore Cty |
dc.contributor.author.fl_str_mv |
Yamane, Érica Sayuri [UNIFESP] Bizerra, Fernando César [UNIFESP] Oliveira, Eduardo B. Moreira, Jéssica Tanaka [UNIFESP] Rajabi, Mohsen Nunes, Gabriel Luiz Cocco [UNIFESP] Souza, Ana O. de Silva, Ismael Dale Cotrim Guerreiro da [UNIFESP] Yamane, Tetsuo Karpel, Richard L. Silva, Pedro I. Hayashi, Mirian Akemi Furuie [UNIFESP] |
dc.subject.por.fl_str_mv |
Rattlesnake toxin Antimicrobial activity Amphipathic peptide Clinical strain |
topic |
Rattlesnake toxin Antimicrobial activity Amphipathic peptide Clinical strain |
description |
Crotamine is a highly basic peptide from the venom of Crotalus durissus terrificus rattlesnake. Its common gene ancestry and structural similarity with the beta-defensins, mainly due to an identical disulfide bond pattern, stimulated us to assess the antimicrobial properties of native, recombinant, and chemically synthesized crotamine. Antimicrobial activities against standard strains and clinical isolates were analyzed by the colorimetric microdilution method showing a weak antibacterial activity against both Gram-positive and Gram-negative bacteria [MIC (Minimum Inhibitory Concentration) of 50->200 mu g/mL], with the exception of Micrococcus luteus [MIC ranging from 1 to 2 mu g/mL]. No detectable activity was observed for the filamentous fungus Aspergillus fumigatus and Trichophyton rubrum at concentrations up to 125 mu g/mL. However, a pronounced antifungal activity against Candida spp., Trichosporon spp., and Cryptococcus neoformans [12.5-50.0 mu g/mL] was observed. Chemically produced synthetic crotamine in general displayed MIC values similar to those observed for native crotamine, whereas recombinant crotamine was overridingly more potent in most assays. On the other hand, derived short linear peptides were not very effective apart from a few exceptions. Pronounced ultrastructure alteration in Candida albicans elicited by crotamine was observed by electron microscopy analyses. the peculiar specificity for highly proliferating cells was confirmed here showing potential low cytotoxic effect of crotamine against nontumoral mammal cell lines (HEK293, PC12, and primary culture astrocyte cells) compared to tumoral B16F10 cells, and no hemolytic activity was observed. Taken together these results suggest that, at low concentration, crotamine is a potentially valuable anti-yeast or candicidal agent, with low harmful effects on normal mammal cells, justifying further studies on its mechanisms of action aiming medical and industrial applications. (C) 2012 Elsevier Masson SAS. All rights reserved. |
publishDate |
2013 |
dc.date.none.fl_str_mv |
2013-02-01 2016-01-24T14:31:09Z 2016-01-24T14:31:09Z |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://dx.doi.org/10.1016/j.biochi.2012.09.019 Biochimie. Paris: Elsevier France-editions Scientifiques Medicales Elsevier, v. 95, n. 2, p. 231-240, 2013. 10.1016/j.biochi.2012.09.019 WOS000315614200012.pdf 0300-9084 http://repositorio.unifesp.br/handle/11600/35889 WOS:000315614200012 |
url |
http://dx.doi.org/10.1016/j.biochi.2012.09.019 http://repositorio.unifesp.br/handle/11600/35889 |
identifier_str_mv |
Biochimie. Paris: Elsevier France-editions Scientifiques Medicales Elsevier, v. 95, n. 2, p. 231-240, 2013. 10.1016/j.biochi.2012.09.019 WOS000315614200012.pdf 0300-9084 WOS:000315614200012 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
Biochimie |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess http://www.elsevier.com/about/open-access/open-access-policies/article-posting-policy |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
http://www.elsevier.com/about/open-access/open-access-policies/article-posting-policy |
dc.format.none.fl_str_mv |
231-240 application/pdf |
dc.publisher.none.fl_str_mv |
Elsevier B.V. |
publisher.none.fl_str_mv |
Elsevier B.V. |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da UNIFESP instname:Universidade Federal de São Paulo (UNIFESP) instacron:UNIFESP |
instname_str |
Universidade Federal de São Paulo (UNIFESP) |
instacron_str |
UNIFESP |
institution |
UNIFESP |
reponame_str |
Repositório Institucional da UNIFESP |
collection |
Repositório Institucional da UNIFESP |
repository.name.fl_str_mv |
Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP) |
repository.mail.fl_str_mv |
biblioteca.csp@unifesp.br |
_version_ |
1814268429013614592 |